BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36097105)

  • 1. Asian-specific 3'UTR variant in CDKN2B associated with risk of pituitary adenoma.
    Youn BJ; Cheong HS; Namgoong S; Kim LH; Baek IK; Kim JH; Yoon SJ; Kim EH; Kim SH; Chang JH; Kim SH; Shin HD
    Mol Biol Rep; 2022 Nov; 49(11):10339-10346. PubMed ID: 36097105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strong association of common variants in the CDKN2A/CDKN2B region with type 2 diabetes in French Europids.
    Duesing K; Fatemifar G; Charpentier G; Marre M; Tichet J; Hercberg S; Balkau B; Froguel P; Gibson F
    Diabetologia; 2008 May; 51(5):821-6. PubMed ID: 18368387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single nucleotide polymorphism in the 3'untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare.
    Kumar R; Smeds J; Berggren P; Straume O; Rozell BL; Akslen LA; Hemminki K
    Int J Cancer; 2001 Nov; 95(6):388-93. PubMed ID: 11668523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma.
    Ghasimi S; Wibom C; Dahlin AM; Brännström T; Golovleva I; Andersson U; Melin B
    J Neurooncol; 2016 May; 127(3):483-92. PubMed ID: 26839018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic association between CDKN2B/CDKN2B-AS1 gene polymorphisms with primary glaucoma in a North Indian cohort: an original study and an updated meta-analysis.
    Thakur N; Kupani M; Mannan R; Pruthi A; Mehrotra S
    BMC Med Genomics; 2021 Jan; 14(1):1. PubMed ID: 33397358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New findings in the roles of Cyclin-dependent Kinase inhibitors 2B Antisense RNA 1 (
    Yuan W; Zhang W; Zhang W; Ruan ZB; Zhu L; Liu Y; Mi YY; Zhang LF
    Bioengineered; 2020 Dec; 11(1):1084-1098. PubMed ID: 33054494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of CDKN2A/CDKN2B with inflammatory bowel disease in Koreans.
    Lee HS; Lee SB; Kim BM; Hong M; Jung S; Hong J; Baek J; Han B; Oh SH; Kim KM; Park SH; Yang SK; Ye BD; Song K
    J Gastroenterol Hepatol; 2018 Apr; 33(4):887-893. PubMed ID: 29063720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6 (IL-6) rs1800796 and cyclin dependent kinase inhibitor (CDKN2A/CDKN2B) rs2383207 are associated with ischemic stroke in indigenous West African Men.
    Akinyemi R; Arnett DK; Tiwari HK; Ovbiagele B; Sarfo F; Srinivasasainagendra V; Irvin MR; Adeoye A; Perry RT; Akpalu A; Jenkins C; Owolabi L; Obiako R; Wahab K; Sanya E; Komolafe M; Fawale M; Adebayo P; Osaigbovo G; Sunmonu T; Olowoyo P; Chukwuonye I; Obiabo Y; Akpa O; Melikam S; Saulson R; Kalaria R; Ogunniyi A; Owolabi M;
    J Neurol Sci; 2017 Aug; 379():229-235. PubMed ID: 28716248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of CDKN2A/B rs4977756 polymorphism on glioma risk: a meta-analysis of 16 studies including 24077 participants.
    Qi X; Wan Y; Zhan Q; Yang S; Wang Y; Cai X
    Mamm Genome; 2016 Feb; 27(1-2):1-7. PubMed ID: 26577493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression.
    Cunnington MS; Santibanez Koref M; Mayosi BM; Burn J; Keavney B
    PLoS Genet; 2010 Apr; 6(4):e1000899. PubMed ID: 20386740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between cyclin-dependent kinase inhibitor 2B antisense RNA 1 and zinc finger homeobox 3 gene polymorphisms and COVID-19 severity.
    Badr EA; Elhelbawy NG; Nagy AO; Sultan AA; Elnaidany SS
    BMC Infect Dis; 2023 Aug; 23(1):568. PubMed ID: 37653506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk.
    Campa D; Pastore M; Gentiluomo M; Talar-Wojnarowska R; Kupcinskas J; Malecka-Panas E; Neoptolemos JP; Niesen W; Vodicka P; Delle Fave G; Bueno-de-Mesquita HB; Gazouli M; Pacetti P; Di Leo M; Ito H; Klüter H; Soucek P; Corbo V; Yamao K; Hosono S; Kaaks R; Vashist Y; Gioffreda D; Strobel O; Shimizu Y; Dijk F; Andriulli A; Ivanauskas A; Bugert P; Tavano F; Vodickova L; Zambon CF; Lovecek M; Landi S; Key TJ; Boggi U; Pezzilli R; Jamroziak K; Mohelnikova-Duchonova B; Mambrini A; Bambi F; Busch O; Pazienza V; Valente R; Theodoropoulos GE; Hackert T; Capurso G; Cavestro GM; Pasquali C; Basso D; Sperti C; Matsuo K; Büchler M; Khaw KT; Izbicki J; Costello E; Katzke V; Michalski C; Stepien A; Rizzato C; Canzian F
    Oncotarget; 2016 Aug; 7(35):57011-57020. PubMed ID: 27486979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Known glioma risk loci are associated with glioma with a family history of brain tumours -- a case-control gene association study.
    Melin B; Dahlin AM; Andersson U; Wang Z; Henriksson R; Hallmans G; Bondy ML; Johansen C; Feychting M; Ahlbom A; Kitahara CM; Wang SS; Ruder AM; Carreón T; Butler MA; Inskip PD; Purdue M; Hsing AW; Mechanic L; Gillanders E; Yeager M; Linet M; Chanock SJ; Hartge P; Rajaraman P
    Int J Cancer; 2013 May; 132(10):2464-8. PubMed ID: 23115063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of CDKN2B-AS1 polymorphisms on the susceptibility to coronary heart disease.
    Huang K; Zhong J; Li Q; Zhang W; Chen Z; Zhou Y; Wu M; Zhong Z; Lu S; Zhang S
    Mol Genet Genomic Med; 2019 Nov; 7(11):e955. PubMed ID: 31496134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA CDKN2B-AS1 contributes to glioma development by regulating the miR-199a-5p/DDR1 axis.
    Lu J; Chen Y; Wen L; Zhou Q; Yan S
    J Gene Med; 2022 Jan; 24(1):e3389. PubMed ID: 34559933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The associations of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene polymorphisms with the risk of Crohn's disease in Chinese patients].
    Xu Y; Shao XX; Hu DY; Rao SY; Xiao HY; Fang Y; Jiang Y
    Zhonghua Yi Xue Za Zhi; 2022 Aug; 102(32):2513-2522. PubMed ID: 36008322
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1.
    Pasmant E; Sabbagh A; Masliah-Planchon J; Ortonne N; Laurendeau I; Melin L; Ferkal S; Hernandez L; Leroy K; Valeyrie-Allanore L; Parfait B; Vidaud D; Bièche I; Lantieri L; Wolkenstein P; Vidaud M;
    J Natl Cancer Inst; 2011 Nov; 103(22):1713-22. PubMed ID: 22034633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association study of the miRNA-binding site polymorphisms of CDKN2A/B genes with gestational diabetes mellitus susceptibility.
    Wang X; Li W; Ma L; Gao J; Liu J; Ping F; Nie M
    Acta Diabetol; 2015 Oct; 52(5):951-8. PubMed ID: 25990668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene expression and rs2383207 variant with breast cancer risk and survival.
    Kattan SW; Hobani YH; Shaheen S; Mokhtar SH; Hussein MH; Toraih EA; Fawzy MS; Abdalla HA
    Cell Mol Biol Lett; 2021 Apr; 26(1):14. PubMed ID: 33849428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.